Navigation Links
EntreMed Announces Changes to Board of Directors and CEO Appointment
Date:4/5/2013

sed in human cancers.  ENMD-2076 also targets the VEGFR, Flt-3 and FGFR3 kinases which have been shown to play important roles in the pathology of several cancers.  ENMD-2076 has shown promising activity in Phase 1 clinical trials in solid tumor cancers, leukemia, and multiple myeloma.  ENMD-2076 is currently completing a Phase 2 trial for ovarian cancer.  EntreMed, Inc. recently initiated a dual-institutional Phase 2 study of ENMD-2076 in triple-negative breast cancer.

Forward Looking Statements           

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance, strategies, expectations and goals.  Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed.

Actual results could differ materially from those currently anticipated due to a number of factors, including: the risk that we may be unable to continue as a going concern as a result of our inability to raise sufficient capital for our operational needs; the possibility that we may be delisted from trading on the Nasdaq Capital Market; the volatility of our common stock; the difficulty of executing our business strategy in China; our inability to enter into strategic partnerships for the development, commercialization, manufacturing and distribution of our proposed product candidate; risks relating to the need for additional capital and the uncertainty of securing additional funding on favorable terms; declines in actual sales of Thalomid® resulting in reduced royalty payments; risks associated with our product candidates; any early-stage products under
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. EntreMed Reports Fourth Quarter And Year-End 2012 Financial Results And Business Outlook For 2013
2. EntreMed To Raise $10.7 Million In Registered Direct Offering
3. EntreMed Announces Initiation Of Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma
4. PNAS Publishes Preclinical Results of EntreMeds 2ME2 for Multiple Sclerosis
5. EntreMed Announces Publication Of Preclinical Results For ENMD-2076 In Triple-negative Breast Cancer
6. Dana-Farber Cancer Institutes Ursula A. Matulonis, MD Article on EntreMeds ENMD-2076 Published in the European Journal of Cancer
7. EntreMed Reports Second Quarter 2012 Financial Results
8. EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
9. EntreMed Reports First Quarter 2012 Financial Results
10. AstraZeneca Announces Top-Line Results From OSKIRA-1 Phase 3 Study of Fostamatinib in Rheumatoid Arthritis
11. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 BioStructures, LLC ... American Association of Tissue Banks (AATB), it was ... Executive Officer. Accreditation follows an intensive ... specially trained AATB inspector.  It establishes that the ... the facility meets or exceeds the standards set ...
(Date:9/30/2014)... , Sept. 30, 2014  Proteomics is a ... a new report from Kalorama Information.  The healthcare market ... occurred in proteomics in the past two years.  ... agreements between private proteomic companies and academic institutions, ... novel proteomics innovator companies.  Kalorama observed the industry ...
(Date:9/30/2014)... , September 30, 2014 ... the CSF (Cerebrospinal Fluid) backflow of the Eldor spinal ... of the single hole pencil point spinal needles of ... Braun. Spinal anesthesia is an excellent type ... Orthopedics, Urology, General Anesthesia, etc. It is ...
Breaking Medicine Technology:Biostructures, LLC Earns AATB Accreditation 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 3
... YORK, March 28, 2011 Havas Drive, the innovation ... of patient-centric services geared toward persons with disabilities and ... Smith—a nationally recognized authority on Web accessibility with a ... Pentagon Library, Kent State,s Knowledge Management program and the ...
... Inc. (Nasdaq: KERX ) (the "Company") today ... presented at the upcoming 102nd annual meeting of the ... in Orlando, Florida, from April 2-6, 2011. Perifosine, the ... Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, is ...
Cached Medicine Technology:Havas Drive Launches New Services Aimed at Improving Digital and Web Accessibility 2Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting 2Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting 3
(Date:9/30/2014)... to slow the spiraling costs of drugs paid for ... had no meaningful impact on cancer chemotherapy drug costs, ... of Clinical Oncology published online today. , "We ... and lung cancers, and did not find a substantial ... implementation of the recent Medicare law in 2005," says ...
(Date:9/30/2014)... by UC Irvine immunologists reveals new information about how ... process that determines how the body,s ability to fight ... Nature Immunology , neurology professor Dr. Michael Demetriou, postdoctoral ... describe a critical mechanism underlying how T cells are ... T cell is a type of blood cell called ...
(Date:9/30/2014)... 2014 Fat Burning Kitchen , the ... author Mike Geary that is helping people learn the truth ... a fat-burning machine in less than 24 hours has caught ... , “In our culture that is becoming so obsessed with ... what is really fact and fiction when it comes to ...
(Date:9/30/2014)... September 30, 2014 Hospice & ... annual “In Celebration” gala, honoring three outstanding individuals ... of striving to provide extraordinary and dignified comfort, ... a serious or life-limiting illness. , The event ... Rye, NY and recognized William (Bill) J. McGuinness, ...
(Date:9/30/2014)... Florida (PRWEB) September 30, 2014 Two revolutionary ... the treatment of gum disease a far less ... the past. , “If you’ve ever felt electric shock waves ... or sip a cold beverage, it’s possible you already know ... , who is a general dentist in West Palm Beach, ...
Breaking Medicine News(10 mins):Health News:Landmark Medicare law had little impact on reducing chemotherapy cost 2Health News:UCI study uncovers important process for immune system development 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 3Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 3
... Painful endometriosis in women could be treated with a ... results of their study have been// published in the ... endometriosis have endometrial tissue developing outside the uterus, which ... a result there is often pain, bleeding, inflammation, infertility ...
... A strong warning was issued by Britain's prime minister to ... that were not-so- healthy to children or face// the risk ... that target minors. ,In a broad address on ... the voluntary regulations failing, the food industry would be forced ...
... used to get a second opinions on mammogram images, which ... slow. // ,In order to speed up the process, ... is able to get useful information from a mammogram database ... image in question to every image of breast cancer in ...
... the Albert Einstein College of Medicine of Yeshiva University ... the malaria disease by using their previous research on ... the August issue of Nature Methods, “should substantially speed ... to Dr. David Fidock, senior author of the paper ...
... experience sharp changes in their hormones once they start ... small monkeys.// ,Yevgenia Kozorovitskiy and her colleagues from ... - small monkeys that live in trees - that ... Scientist. ,The species is rare among mammals ...
... Curie Cancer Care hospice in Belfast, which has marked a major ... provisions for 18 individual en-suite rooms each of which open out ... provide for a family member to stay overnight with the patient. ... claimed that there were still more improvements to come. ...
Cached Medicine News:Health News:Google-Like Model Used To Diagnose Suspicious Breast Masses Quickly 2Health News:Malaria Truths Discovered By Einstein Researchers 2
... is a powerful magnifier that helps the partially sighted ... a hand magnifier attached to a pair of electronic ... no need for a TV set. The display is ... on a book, a can of food, a medicine ...
... vision to see objects at a distance, ... between. This battery operated system can be ... used as a desktop video magnifier when ... easy to use and requires no special ...
... general purpose incubators designed to ... and uniformity required for the ... versatile microprocessor controlled incubators feature ... easy-to-read digital display, and built-in ...
... general purpose incubators designed to ... and uniformity required for the ... versatile microprocessor controlled incubators feature ... easy-to-read digital display, and built-in ...
Medicine Products: